15th July 2019
Effective 1 January 2018
The Boards of EIT Health Germany and EIT Health UK-Ireland, respectively, are pleased to announce the appointment of Dr. Katharina Ladewig as Managing Director, EIT Health Germany, effective 1 January 2018. Dr. Ladewig has been an active member of the EIT Health community since its incorporation phase, and led the UK-Ireland Regional Innovation Hub (RIH) as Managing Director since October 2015.
“We are delighted that Katharina will remain in EIT Health. From the UK and Ireland perspective, we are proud of her leadership and success, and grateful for all her efforts in building EIT Health’s momentum. We believe this transition will be to all our benefits, with Katharina linking the CLCs and catalysing future co-operation. It is a wonderful example, of how EIT Health can promote mobility and co-operation and promote our best people to new opportunities for their career development.” says Prof Bass Hassan (Chairman of the Board of Directors, EIT Health UK-Ireland)
“With the appointment of Dr. Ladewig we chose a leader, who will enthusiastically drive forward the position of the German CLC within the EIT Health community as well as its role in the European health innovation ecosystem.” adds Dr. Volker Lodwig (Board of Directors, EIT Health Germany).
With her appointment to the role of Managing Director EIT Health Germany, Dr. Ladewig follows in the footsteps of Dr. Armin Pscherer, who left the organisation in March 2017. Until the appointment of her successor in the UKI CLC (anticipated for early 2018), Dr. Ladewig will continue to manage the day-to-day business of EIT Health UK-Ireland.
How can young scientists move to innovation roles?
Q&A with Carmen Schweicker
EIT Health named top business accelerator by UBI Global
Learn more about the achievement
Arthex Biotech closes a €42M Series B financing round
Find out more about our support